Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL Behring, which makes medicines for rare bleeding disorders, recently hosted hematology/oncology fellows at an in-person l…
A new study looked at the worldwide prevalence of VWD, a bleeding disorder. It found reported cases were much higher in wealt…
Pools, hot tubs and natural bodies of water can be great fun, but watch out for water-borne illnesses, experts say.
As more gene therapy treatments are approved, this framework can help patients work with their doctors to make decisions abou…
CSL Seqirus has started shipping influenza vaccines to health care providers in the United States, helping them get prepared …
Speak to your local organization about the nomination process and learn more about CSL Behring's Gettin' In the Game Junior N…
Apply today for a weekend workshop designed to help partners better weather the challenges of hemophilia B.
The best and brightest among Australian researchers are invited to apply for two awards worth more than $1 million over five …
The Immune Deficiency Foundation (IDF) is about to start walking in eight U.S. cities to support the nonprofit organization’s…
Americas
Asia Pacific
Middle East
Europe